Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on May 5, 2025
Dogecoin Whales have Accumulated about 100 million DOGE tokens While Trader’s Eyes are on PaladinMining to Earn Massive Returns
GlobeNewswire
·
May 5, 2025
London, UK, May 05, 2025 (GLOBE NEWSWIRE) -- Dogecoin continues to show bullish signals while 100 million DOGE tokens accumulated by the whales have further strengthened it – making it highly desirable for traders. As Crypto analysts suggest a price surge …
Aterian Sets Date for First Quarter 2025 Earnings Announcement & Investor Conference Call
GlobeNewswire
·
May 5, 2025
SUMMIT, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”), a technology-enabled consumer products company, today announced that it will issue its financial results for the first quarter ended March 31, 2025 on …
Shoals Technologies Group, UGT Renewables and Sun Africa Announce Collaboration on up to 12GW of Solar Projects
GlobeNewswire
·
May 5, 2025
PORTLAND, Tenn., May 05, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (Nasdaq: SHLS), a global leader in electrical balance of system (EBOS) solutions for the energy transition market, announced today the execution of a Memorandum of …
Hudbay Publishes 2024 Annual Report, “Built to Grow”
GlobeNewswire
·
May 5, 2025
TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) today announced the release of its 2024 annual report (“Annual Report”) which provides insight and transparency on key business, operating and …
Context Therapeutics Announces Chief Medical Officer Transition
GlobeNewswire
·
May 5, 2025
PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced Dr. Karen Smith, …
Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates
GlobeNewswire
·
May 5, 2025
Cash runway extended into 2029 Initiation of Phase 3 ReDiscover-2 trial on track for mid-2025 Initiated Phase 1 RLY-2608 vascular malformations clinical trial in Q1 Extended cash runway expected to fully fund the Company meaningfully past topline data for …
ServiceTitan to Announce Fiscal First Quarter 2026 Financial Results on June 5, 2025
GlobeNewswire
·
May 5, 2025
LOS ANGELES, May 05, 2025 (GLOBE NEWSWIRE) -- ServiceTitan, Inc. (Nasdaq: TTAN), the software platform that powers the trades, today announced that it will report its financial results for the fiscal first quarter ended April 30, 2025 after market close on …
Mineralys Therapeutics to Announce First Quarter 2025 Financial Results and Host Conference Call on Monday, May 12, 2025
GlobeNewswire
·
May 5, 2025
RADNOR, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and …
FibroGen to Report First Quarter 2025 Financial Results
GlobeNewswire
·
May 5, 2025
SAN FRANCISCO, May 05, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce first quarter 2025 financial results on Monday, May 12 after the markets close. FibroGen will also conduct a conference call on that day at 5:00 PM Eastern Time …
Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 5, 2025
MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the …
ORIC® Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Updates
GlobeNewswire
·
May 5, 2025
Announced focused registrational clinical development plans for lead programs, extended cash runway, and accelerated/augmented corporate milestones Presented preclinical data supporting potential best-in-class profile of ORIC-944 in combination with AR …
uniQure to Announce First Quarter 2025 Financial Results
GlobeNewswire
·
May 5, 2025
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, May 05, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs will report first quarter 2025 financial …
red violet to Participate in the 20th Annual Needham Technology, Media, & Consumer Conference
GlobeNewswire
·
May 5, 2025
BOCA RATON, Fla., May 05, 2025 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced that it will participate in the 20th Annual Needham Technology, Media, …
Immuneering Reports First Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire
·
May 5, 2025
- Progression-free survival data from more than 30 patients with first line pancreatic cancer in the ongoing Phase 2a trial of IMM-1-104 trial planned for announcement in 2Q’25 - - Reported positive data from the Company’s ongoing Phase 2a trial of lead …
ARRAY Technologies Enhances ARRAY STI H250™ Tracker with SmarTrack® Backtracking and Diffuse Capabilities
GlobeNewswire
·
May 5, 2025
ALBUQUERQUE, N.M., May 05, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology products, software and services, today announced the expansion of its SmarTrack® …
Celldex Presents Histology Data from Phase 2 Study of Barzolvolimab in EoE Supporting Potential of Mast Depleting Agent in this Difficult to Treat Disease
GlobeNewswire
·
May 5, 2025
HAMPTON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Celldex announced today the presentation of histology data from the Company’s ongoing Phase 2 study of barzolvolimab in eosinophilic esophagitis (EoE). Biopsies taken during screening demonstrate the presence …
Editas Medicine to Announce First Quarter 2025 Financial Results and to Participate in Investor Conference in May
GlobeNewswire
·
May 5, 2025
CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that it plans to announce Q1 2025 financial …
Coherus to Report First Quarter 2025 Financial Results on May 12, 2025
GlobeNewswire
·
May 5, 2025
REDWOOD CITY, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that its first quarter 2025 financial results will be released after market close on Monday, May 12, 2025. Starting at 5:00 p.m. EDT …
Global Leader in Thermal Management Laird Thermal Systems Unveils New Identity
EIN Presswire
·
May 5, 2025
ROSENHEIM, GERMANY, May 5, 2025 /EINPresswire.com/ -- Laird Thermal Systems, a global leader in active thermal management solutions with more than 60 years of application expertise, today announced its rebrand to Tark Thermal Solutions. This name change …
Programmers.io Among the First Globally to Achieve ISO/IEC 42001:2023 (AIMS) Standard for Artificial Intelligence
EIN Presswire
·
May 5, 2025
Programmers.io earns ISO/IEC 42001:2023 and 27001:2022 certifications, showcasing global leadership in ethical AI governance and robust information security. DALLAS, TX, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- Programmers.io, a technology …